
NewsFOX 13 Tampa BayOctober 29, 2026Hillsborough County
Health and Human Services eases restrictions on compounding certain unapproved peptides
Photo: FOX 13 Tampa Bay
The Department of Health and Human Services announced a policy allowing licensed pharmacies and physicians to compound six unapproved peptides without facing Food and Drug Administration enforcement. The interim policy applies as long as compounders meet standards for ingredient quality, manufacturing, safety reporting, labeling, and patient-specific prescriptions.
Read the full story at FOX 13 Tampa BayWhy It Matters
Patients gain broader access to specific unapproved through licensed compounders while federal regulators evaluate their potential inclusion in compounded medicines, altering enforcement risks for pharmacies and physicians.
Key Facts
- Health and Human Services introduced an interim policy allowing licensed pharmacies and physicians to compound six unapproved peptides without facing Food and Drug Administration enforcement.
- The six peptides covered by the policy include BPC-157, TB-500, epitalon, KPV, MOTS-c, and Semax.
- Compounders must meet standards on ingredient quality, manufacturing requirements, safety reporting, labeling, and patient-specific prescriptions to avoid enforcement action.
- HHS officials stated the policy aims to deter the use of research-use-only peptides from foreign manufacturers that pose safety risks while improving patient access.
- Peptides have grown in popularity over the past year, supported by wellness influencers for uses ranging from anti-aging to muscle recovery and tissue repair.
- Peptides are short chains of amino acids naturally produced by the body that regulate functions like hormone signaling, immune response, and tissue repair.
Who's Mentioned
otherSemax“peptide allowed for migraines and persistent pain”otherTB-500“peptide allowed for compounding”PersonMelinda Ring“director of the Osher Center for Integrative Health at Northwestern University F”otherepitalon“peptide allowed for compounding for insomnia”OrganizationHealth and Human Services“federal agency advancing the policy”OrganizationFood and Drug Administration“regulator determining use of peptides in compounded medicines”OrganizationNorthwestern University Feinberg School of Medicine“institution where Dr. Melinda Ring works”otherKPV“peptide allowed for wound healing and inflammatory conditions”otherMOTS-c“peptide allowed for obesity and osteoporosis”OrganizationReuters“reported on the federal agency's policy”otherBPC-157“peptide allowed for compounding”PersonRobert F. Kennedy“HHS Secretary who advocated for wider access to peptides”
